Clinical trial
Bevacizumab, Etoposide and Cisplatin Followed by Whole Brain Radiotherapy in…
NCT02185352 · National Taiwan University Hospital, Other · Unknown status
Key facts
| NCT number | NCT02185352 |
|---|---|
| Title | Bevacizumab, Etoposide and Cisplatin Followed by Whole Brain Radiotherapy in Breast Cancer With Brain Metastases |
| Official title | Randomized Phase II Study of Induction Bevacizumab, Etoposide and Cisplatin Followed by Whole Brain Radiotherapy (WBRT) Versus WBRT Alone in Breast Cancer With Untreated Brain Metastases |
| Acronym | A-Plus |
| Lead sponsor | National Taiwan University Hospital, Other |
| Status | Unknown status |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Breast Cancer, Brain Metastases |
| Intervention type | Drug |
| Interventions | BEEP regimen |
| Enrollment | 120 |
| Start date | Apr 21, 2014 |
| Primary completion | Nov 1, 2019 |
| Completion | Nov 1, 2022 |
| First posted | Jul 9, 2014 |
| Last update posted | May 7, 2021 |
| Countries | Taiwan |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: